Alizyme Share Discussion Threads

[silverbackalpha] 29/6/2009 10:31

Goodman is at the helm now.

The company I would guess has a estimated 90% chance of bankruptcy or liquidation.

If money can be raised then there is a chance of survival, to be able to get the milestone payments. That will buy time to keep the hope of ceti alive.

Not sure how much needs to be raised.

I doubt existing management will be around in 3-4 months time. There is a reasonable chance the company will be in liquidation by then.

[the_doctor] 29/6/2009 10:11

Yeah right - they probably wouldnt want them!
& if the rights are worth anything, why would Takeda let others buy ceti rights and then pay more to buy off them?


Wakeland - 29 Jun'09 - 09:57 - 23759 of 23761
Directors will let this go under, they probably already have some investment vehicle that will pick up the rights for next to nothing

[15joe] 29/6/2009 10:08

I bet McCarthy is 'out of the office' for good. Looks like Goodman will be at the helm.

[wakeland] 29/6/2009 09:57

Directors will let this go under, they probably already have some investment vehicle that will pick up the rights for next to nothing just in case one of them does amount to anything, McCarthy cannot be trusted, his salary alone has put the Co. under.

[peaeff] 29/6/2009 09:55

Good morning and commiserations to all of you who are left in at the present time. The news this morning is devastating and I believe, one could say, unexpected at this particular juncture in time.

My losses, in this company, were large enough but I am able to look back now and feel comforted by the fact that a decision made a couple of months ago, has at least saved me a couple of grand.

I hope that something can be done, in the form of a rescue package, to at least keep the company afloat, until the phaseIII Japan results are known. Should they turn out to be positive then you will at least be able to salvage something from this mess.

Looking back over the last 3-4 years, because all seemed rosy before that, it is quite clear that the management have been less than 'up front' with the information they have been giving to both PI's and to the institutions alike. Over the last couple of years, since things hit the skid pan, I think the words 'up front' tend to degenerate into another category and, at best, can only be described as totally speculative guesswork which is proving to be totally incorrect.

What has happened to this wonderful relationship supposedly moulded with TAKEDA, a company with billion yen budgets, a company which stands to make more billions should Cetilistat ever get to the market place. They are well into phaseIII by now and, I would suggest, that if they feel that there is a chance of that happening, would it hurt their bank balance to stump up a milestone payment a few months before it is due. Of course it wouldn't. Would it hurt the other partners who are running trials to cough up a few quid, in advence. Of course it wouldn't.

What about our institutional shareholders, I would imagine they are still smarting about the misinformation they were given when they stumped up 50p a share last time. However a few measly million may just see this company over the hill and insure their investments.

None of these things seem about to happen and, sadly, TM has had to 'at last' tell it as it actually is, DESPARATE, and that despite his recent assurances on the subject of finances.

Good luck to all of you I hope there is some light at the end of, what has been, a very dark and long tunnel.

Regards PF

[silverbackalpha] 29/6/2009 09:49

filbert: take it for what it is.

It isn't something you are proud of.

Guess all the warning signs were there: Tim not answering calls, Resignations, no deal.

He has certainly lied or misled investors from where I look at things.

[silverbackalpha] 29/6/2009 09:35

This is hilarious. The company tells investors they are going to go under, and "buying interest is returning apparently. the dellusion of it makes my jaw drop.

This company will not be around in 1 years time, I am fairly sure of it.




Johndee - 29 Jun'09 - 09:16 - 23752 of 23754


don't be too negative as buying interest seems to be returning.......some people are positive still obviously.

[loafofbread] 29/6/2009 09:20

10p would be more likely.

[loafofbread] 29/6/2009 09:19

How can there be "potential significantly increased funding obligations" when Alizyme have continually said the funding of ColalPred and Cetilistat is entirely by the existing partners

It does look as though someone has read the small print and found that the contracts were not as water tight as Tim lead us to believe.

Can't see any other reason for them to blow up in our faces.

[johndee] 29/6/2009 09:16

don't be too negative as buying interest seems to be returning.......some people are positive still obviously.

[silverbackalpha] 29/6/2009 09:15

LOL!!

I told you all didnt I!!!

Belly UP!!

He did it he robbed the shareholders in broad daylight and looks like he blatantly lied to everyone. Isnt there some criminal redress here?????

Grossly misleading statements????

How can I go about reporting him, and also trying to confiscate income earned??

[fidra] 29/6/2009 09:07

Actually the amount invested was way short of a couple of hundred milion.I think it was around £150M.And probably a lot less

[the_doctor] 29/6/2009 08:59

Did the products ever look great amt? NO - as proven by the lack of deals with majors in western markets.

[amt] 29/6/2009 08:58

Shows the risks of Biotec companies which it seems to me in 90% of cases fail so not worth investing in. Hundreds of millions of pound invested over the years in Alizyme and nothing (for shareholders) to show for it. Cost me a couple of thousand over the years. Only consolation was that I made a small contibution to healthcare and scientific advance.

[uggly buggly] 29/6/2009 08:56

CRASH.....BANG.....WALLOP

[the_doctor] 29/6/2009 08:55

joeblogg - yes, I always have.

It is very easy to quote '$1bn market' etc.
In fact, AZM uses outdated forecasts.

Look at the clinical data, the product really doesnt do much. Sure, it works a little, but not enough to warrant the cost IMO.

Still, for you holders, I'd be happy to see them get a deal and I dont see that as impossible! Similarly, with the right marketing, ceti still could be valuable.

[joeblogg1000] 29/6/2009 08:46

the doc. are u saying ceti. is no good??

[troutfish] 29/6/2009 08:44

Market cap = £7.01m at share price 3.5p

Only need a 1 new for 7 old share issue to raise £1m [i.e. not much diluton] which should see them through to the Phase 3 Cetilistat Japan results in H2 2010, especially if they make further savings.

P.S.
Would like to have seen a menton in todays Update that McCarthy would cut his total remuneration [salary, pension, expenses, etc] to below £100k.

[the_doctor] 29/6/2009 08:41

It isnt particularly anyone's fault. Sure, Palmer missed an opp. but at that time, confidence was riding high.
It's unfortunately just that the regulatory environment changed for renza. Colal really was very unlucky and ceti is well.... it doesnt do anything really!

Tim actually did an amazing job of getting in funds before, which most seem to forget.

[troutfish] 29/6/2009 08:39

How can there be "potential significantly increased funding obligations" when Alizyme have continually said the funding of ColalPred and Cetilistat is entirely by the existing partners?

If they do go into administraton but Cetilistat Japan passes Phase 3 next year, presumably the administrators would be able to return all the future Cetilistat Japan milestone cash to shareholders - which would be a lot more than the current market cap?

How on earth could McCarthy only have cut his salary by 30% in April (still getting approximately a massive £346k pa total remuneration) under these circumstances?


They only need to last until Phase 3 Cetilistat Japan results are out next year after which the Company should be cash rich and made. Surely the institutons will stump up £1 million to allow them to survive until them?

If not surely they could outlicense ATL104?

[johndee] 29/6/2009 08:36

The mm's could drop this to 1 penny before we see any buying.......